FDA authorizes BioNTech and Pfizer's COVID-19 booster for 16- and 17-year-olds
FDA authorizes BioNTech and Pfizer's COVID-19 booster for 16- and 17-year-olds
MarketWatch
0 shares
1 views
You might like
Related news coverage
FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up
Newsy
Watch VideoThe U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's..
-
FDA expected to authorize Pfizer-BioNTech booster shots for 12-to-15-year-olds by early next week
Washington Post
-
Following FDA lead, CDC recommends Pfizer/BioNTech booster for 16 and 17-year-olds
SeekingAlpha
-
FDA expands Pfizer COVID booster, opens extra dose to age 16
SeattlePI.com
-
Pfizer/BioNTech COVID-19 booster authorization lowered to 16 years by FDA
SeekingAlpha
Advertisement
More coverage
US FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds
Jerusalem Post
All US adults are currently eligible for booster shots of the three authorized COVID-19 vaccines.